Published October 10, 2024
0 views Journal article Open Access Open Access

Anthrax: A narrative review.

  • 1. School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India.
  • 2. Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences & Research, Durgapur, 713212, West Bengal, India.
  • 3. Department of Microbiology, Ramakrishna Mission Vivekananda Centenary College, Rahara, Kolkata, 700118, West Bengal, India.
  • 4. UNESCO Regional Centre for Biotechnology, Department of Biotechnology, Government of India, NCR Biotech Science Cluster, Faridabad, 121001, Haryana, India.
  • 5. Department of Pharmaceutics, Yenepoya Pharmacy College & Research Centre, Yenepoya (Deemed to be University), Mangalore, Karnataka, 575018, India.
  • 6. Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, India.
  • 7. Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, India.
  • 8. Uttaranchal Institute of Pharmaceutical Sciences, Uttaranchal University, Dehradun, 248007, Uttarakhand, India.
  • 9. Department of Medical Sciences, School of Medical and Life Sciences, Sunway University, Bandar Sunway, 47500, Selangor Darul Ehsan Malaysia.
  • 10. Jeffrey Cheah School of Medicine and Health Sciences, Monash University, Malaysia, Jalan Lagoon Selatan, Bandar Sunway, 47500, Selangor Darul Ehsan, Malaysia.
  • 11. Monash University

Description

Bacillus anthracis is a zoonotic bacterium, majorly responsible for causing human anthrax and the possibility of the outbreak spreading globally. Herbivorous animals serve as the inherent reservoir for the disease, whereas all endothermic species are vulnerable. Humans contract the disease inadvertently by contact with diseased animals or animal products or through the consumption or handling of infected flesh. There is no such reported data indicating the transmission of anthrax from human to human, which further does not guarantee the bacterium's mutations and new transmission route. Nevertheless, it can lead to various infections, including endophthalmitis, bacteremia, cutaneous infection, central nervous system infection, and pneumonia. Therefore, it is crucial to examine the present epidemiological situation of human anthrax in densely populated nations, including the altered symptoms, indications in people, and the method of transmission. This article highlights the current diagnostic methods for human anthrax, further examines the available therapy options and future perspectives in treatment protocol. This narrative review resulted from a simple search strategy on "PubMed", "ScienceDirect", "ClinicalTrials.gov" and web reports using "AND" as Boolean operator with search keywords, i.e., "Anthrax" AND "Infection", "Anthrax" AND "Pandemic", "Anthrax" AND "Infectious disease", "Anthrax" AND "Vaccine", "Anthrax" AND "Diagnosis" shows minimal narrative literature in between 2024 and 2005. Furthermore, this narrative review highlights the potential approaches for detecting anthrax infection, establishing suitable protocols for prevention, and focusing on the current epidemiology and available therapeutics, vaccine and its future developmental strategies for the prevention of infectious disorder.
Enabled by The Lens

Open Access

Licence Attribution (CC BY)
Publisher Website Access full text